Novel Small Interfering RNA–Containing Solution Protecting Donor Organs in Heart Transplantation
Open Access
- 22 September 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 120 (12), 1099-1107
- https://doi.org/10.1161/circulationaha.108.787390
Abstract
Background— Ischemia/reperfusion injury is a major factor in graft quality and subsequent function in the transplantation setting. We hypothesize that the process of RNA interference may be used to “engineer” a graft to suppress expression of genes associated with inflammation, apoptosis, and complement, which are believed to cause ischemia/reperfusion injury. Such manipulation of pathological gene expression may be performed by treatment of the graft ex vivo with small interfering RNA (siRNA) as part of the preservation procedure. Methods and Results— Heart grafts from BALB/c mice were preserved in UW solution (control) or UW solution containing siRNAs targeting tumor necrosis factor-α, C3, and Fas genes (siRNA solution) at 4°C for 48 hours and subsequently transplanted into syngeneic recipients. Tumor necrosis factor-α, C3, and Fas genes were elevated by ischemia/reperfusion injury after 48 hours of preservation in UW solution. Preservation in siRNA solution knocked down gene expression at the level of messenger RNA and protein in the grafts after transplantation. All grafts preserved in siRNA solution showed strong contraction, whereas grafts preserved in control solution demonstrated no detectable contraction by high-frequency ultrasound scanning. siRNA solution–treated organs exhibited improved histology and diminished neutrophil and lymphocyte infiltration compared with control solution–treated organs. Furthermore, the treated heart grafts retained strong beating up to the end of the observation period (>100 days), whereas all control grafts lost function within 8 days. Conclusion— Incorporation of siRNA into organ storage solution is a feasible and effective method of attenuating ischemia/reperfusion injury, protecting cardiac function, and prolonging graft survival.Keywords
This publication has 40 references indexed in Scilit:
- Toll-Like Receptor 4 Mediates the Early Inflammatory Response After Cold Ischemia/ReperfusionTransplantation, 2007
- TNF-α Contributes to Endothelial Dysfunction by Upregulating Arginase in Ischemia/Reperfusion InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- C5aR-mediated myocardial ischemia/reperfusion injuryBiochemical and Biophysical Research Communications, 2007
- Insights from knock-out models concerning postischemic release of TNFα from isolated mouse heartsJournal of Molecular and Cellular Cardiology, 2007
- Protection of Renal Ischemia Injury using Combination Gene Silencing of Complement 3 and Caspase 3 GenesTransplantation, 2006
- Prevention of Renal Ischemic Injury by Silencing the Expression of Renal Caspase 3 and Caspase 8Transplantation, 2006
- Preventing Renal IschemiaReperfusion Injury Using Small Interfering RNA by Targeting Complement 3 GeneAmerican Journal of Transplantation, 2006
- The role of mitochondria in ischemia/reperfusion injury in organ transplantationKidney International, 2004
- A PHASE I TRIAL OF IMMUNOSUPPRESSION WITH ANTIIC AM-1 (CD54) mAb IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1993
- Electrocardiographic monitoring of cardiac transplants in miceCardiovascular Research, 1988